News

Pharmaceutical News

Pharmaceutical News

Sanofi Ends Deal with Mannkind for Afrezza Inhaled Insulin

  • Date: 01-07-2016 --
  • 01/06/16, Pharmaceutical Business Review
  • body: Sanofi has ended its collaboration with MannKind for the development and commercialization of Afrezza (insulin human) inhalation powder. MannKind is reviewing its strategic options for Afrezza as a result of the termination of its license and collaboration agreement. The termination will take effect no later than six months or July 4, 2016.
  • URL: http://multibriefs.com/ViewLink.php?i=568d311b4a25c